Literature DB >> 12736798

First report of clinical and microbiological failure in the eradication of glycopeptide-intermediate methicillin-resistant Staphylococcus aureus carriage by mupirocin.

J W Decousser1, P Pina, J C Ghnassia, J P Bedos, P Y Allouch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12736798     DOI： 10.1007/s10096-003-0929-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  8 in total

1.  Intranasal mupirocin to prevent postoperative infections.

Authors:  Christof von Eiff; Frank Kipp; Karsten Becker
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

Review 2.  MRSA patients: proven methods to treat colonization and infection.

Authors:  J M Boyce
Journal:  J Hosp Infect       Date:  2001-08       Impact factor: 3.926

3.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

Authors:  K Hiramatsu; N Aritaka; H Hanaki; S Kawasaki; Y Hosoda; S Hori; Y Fukuchi; I Kobayashi
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

Review 4.  The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice.

Authors:  B D Cookson
Journal:  J Antimicrob Chemother       Date:  1998-01       Impact factor: 5.790

5.  Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital.

Authors:  F Guerin; A Buu-Hoï; J L Mainardi; G Kac; N Colardelle; S Vaupré; L Gutmann; I Podglajen
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

6.  In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model.

Authors:  George P Allen; Raymond Cha; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

7.  Staphylococcus aureus resistant to vancomycin--United States, 2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-07-05       Impact factor: 17.586

8.  The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals.

Authors:  F J Schmitz; E Lindenlauf; B Hofmann; A C Fluit; J Verhoef; H P Heinz; M E Jones
Journal:  J Antimicrob Chemother       Date:  1998-10       Impact factor: 5.790
  8 in total
  7 in total

1.  Amplification of the gene for isoleucyl-tRNA synthetase facilitates adaptation to the fitness cost of mupirocin resistance in Salmonella enterica.

Authors:  Wilhelm Paulander; Dan I Andersson; Sophie Maisnier-Patin
Journal:  Genetics       Date:  2010-02-22       Impact factor: 4.562

Review 2.  Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.

Authors:  Julian Gregston Hurdle; Alexander John O'Neill; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  Phenotypic and genotypic mupirocin resistance among Staphylococci causing prosthetic joint infection.

Authors:  Margalida Rotger; Andrej Trampuz; Kerryl E Piper; James M Steckelberg; Robin Patel
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Antibacterial activity of REP8839, a new antibiotic for topical use.

Authors:  Ian A Critchley; Casey L Young; Kimberley C Stone; Urs A Ochsner; Joseph Guiles; Ted Tarasow; Nebojsa Janjic
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

5.  In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus.

Authors:  Mark S Rouse; Margalida Rotger; Kerryl E Piper; James M Steckelberg; Matthew Scholz; Jeffrey Andrews; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  Analysis of mupirocin resistance and fitness in Staphylococcus aureus by molecular genetic and structural modeling techniques.

Authors:  Julian Gregston Hurdle; Alexander John O'Neill; Eileen Ingham; Colin Fishwick; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

7.  Phenotypic and molecular characterization of Staphylococcus aureus isolates expressing low- and high-level mupirocin resistance in Nigeria and South Africa.

Authors:  Adebayo O Shittu; Edet E Udo; Johnson Lin
Journal:  BMC Infect Dis       Date:  2009-01-28       Impact factor: 3.090
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.